Financial News · Live Terminal

Page 390 of 555

Huron Consulting Well-Positioned to Continue Capitalizing on Growth in Core Verticals, Wedbush Says

Huron Consulting (HURN) remains well-positioned to continue capitalizing on growth in its core verticals, Wedbush analysts said in a Wednesday note.Analysts said that more customers are turning to Huron Consulting for assistance in navigating market volatility.Wedbush said that the company's Q1 financial results beat expectations across the board and reaffirmed its "conservative" full-year revenue guidance.Analysts lowered their 2026 adjusted earnings estimate for the company to $8.81 per share from $8.82. Analysts polled by FactSet expect $8.84.Wedbush retained an outperform rating and $160 price target on the stock.Price: $115.52, Change: $-16.70, Percent Change: -12.63%

$HURN

Wire99d ago

Loop Capital Adjusts Price Target on Skyworks Solutions to $70 From $60

Skyworks Solutions (SWKS) has an average rating of hold and mean price target of $70.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $64.84, Change: $-7.73, Percent Change: -10.65%

$SWKS

Wire99d ago

BNP Paribas Adjusts Price Target on Corteva to $77 From $74

Corteva (CTVA) has an average rating of overweight and mean price target of $86.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $81.41, Change: $-2.49, Percent Change: -2.97%

$CTVA

Wire99d ago

Update: Market Chatter: Eli Lilly Plans to Sell About $8 Billion of Bonds to Fund Acquisitions

(Updates with the company's response in the fourth paragraph.)Eli Lilly (LLY) is looking to raise about $8 billion from an investment-grade bond sale to fund an acquisition spree, Bloomberg reported Wednesday, citing people with direct knowledge of the matter.The company is offering notes in as many as eight tranches, with maturities ranging from two to 40 years, according to the report.Proceeds will be used for general corporate purposes and potentially fund all or part of the upfront cash consideration and related expenses linked to the Centessa Pharmaceuticals (CNTA) and Kelonia Therapeutics acquisitions, Bloomberg said.An Eli Lilly spokesperson said the company is excited to be in the investment-grade market. Following strong Q1 earnings, an upgrade from S&P to AA- with a positive outlook, and a favorable market backdrop, Lilly is encouraged by investor interest, the spokesperson added.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $992.35, Change: $+3.48, Percent Change: +0.35%

$CNTA$LLY

Wire99d ago

Blue Moon Metals Closes C$156.23-Million Bought-Deal Share Offerings; Shares up 5.6%

Blue Moon Metals (MOON.V) on Wednesday said it closed a bought-deal public offering of shares and concurrent bought deal private placement, raising C$156.23 million.The company sold underwriters 10.63-million shares priced at C$10.00 in the public offering, raising C$106.23 million, including the partial exercise of the underwriters' over-allotment option.The concurrent private placement sold five-million shares at the same price for proceeds of C$50 million.The proceeds are expected to be used for construction of the Nussir and Blue Moon projects, development capital for the Springer Tungsten and Apex projects, additional exploration at the foregoing projects, working capital, U.S. growth activities and general and administrative and corporate activities.The company's shares were last seen up $0.51 to $9.60 on the TSX Venture Exchange.Price: $9.60, Change: $+0.51, Percent Change: +5.61%

$MOON.V

Wire99d ago

Rothschild & Co Redburn Adjusts Live Nation Entertainment Price Target to $195 From $193

Live Nation Entertainment (LYV) has an average rating of overweight and mean price target of $185.78, according to analysts polled by FactSet.Price: $168.56, Change: $+11.30, Percent Change: +7.19%

$LYV

Wire99d ago

Jefferies Raises Williams Price Target to $87 From $83

Williams (WMB) has an average rating of overweight and mean price target of $82.14, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $74.38, Change: $-1.74, Percent Change: -2.29%

$WMB

Wire99d ago

Logitech International Fiscal Q4 Results Highlight Resilient Model, Wedbush Says

Logitech International (LOGI) demonstrated a resilient operating model in fiscal Q4, with strong execution across product innovation, cost discipline, and supply chain optimization supporting gross and operating margin expansion ahead of expectations, Wedbush Securities said in a Wednesday note.The company continues to execute on its strategic priorities, including growing its B2B business, increasing market share in China, reviving video collaboration, and reinforcing its leadership in personal workspace solutions, the report said.Despite weak PC shipments and higher component costs, Logitech is lifting average selling prices through new products and improved marketing, with strong demand for the G Pro X2 Superstrike underscoring premium execution and gaming growth, the Wedbush analysts said.The analyst cited Logitech's large PC "white space" opportunity and low upgrade penetration, saying improved marketing could drive growth, while net cash supports buybacks, dividends, and acquisitions into 2027.Wedbush maintained its outperform rating on the stock with a price target of $135.Price: $102.55, Change: $-2.87, Percent Change: -2.72%

$LOGI

Wire99d ago

Advanced Micro Devices Sales to Accelerate in Q2 From Unit and Average Selling Price Gains, Wedbush Says

Advanced Micro Devices' (AMD) sales are expected to accelerate in Q2 from a combination of unit and average selling price gains with demand attributable to compute racks powering AI, Wedbush said in a Wednesday research report.While management expects ramp for the MI450/455 GPUs in H2, the strength in CPUs offers somewhat insurance if GPU growth lags expectations, according to the note.Robust enterprise sales influenced by data center growth more than offsets expected weakness in the gaming segments, the firm said. The brokerage said it expects Q2, 2026, and 2027 EPS of $1.61, $6.95, and $12.33, respectively.The company's compute strength reinforces the view that AI infrastructure spending is accelerating faster-than-expected on agentic workloads, the brokerage stated.The brokerage said it reiterated its outperform rating on the stock and boosted its price target to $450 per share from $400.Price: $409.02, Change: $+53.76, Percent Change: +15.13%

$AMD

Wire99d ago

Neurocrine Posts Strong Q1 as Key Treatments Drive Growth, Morgan Stanley Says

Neurocrine Biosciences (NBIX) delivered a strong Q1, powered by rising demand for Ingrezza, its leading treatment for involuntary muscle movements, and an encouraging early launch of Crenessity, a new hormone-related therapy, Morgan Stanley said Wednesday in a report.Ingrezza demand is tracking above the company's 2026 guidance, supported by record new patient starts, durable persistence and no inventory effects or other one-time items in the quarter, the report said.Crenessity is a "definitive blockbuster in the making" with current sales reflecting only a fraction of its eventual potential as the launch remains early, Morgan Stanley said.Neurocrine's acquisition of Soleno Therapeutics (SLNO) is expected to close around July 6, the report said.Morgan Stanley raised its price target on Neurocrine stock to $191 from $185 and maintained its equal-weight rating.Price: $145.19, Change: $+10.13, Percent Change: +7.50%

$NBIX$SLNO

Wire99d ago

Lucid Shares to Remain Under Pressure Until New CEO Reviews Outlook, Morgan Stanley Says

Lucid (LCID) shares are expected to remain under pressure until incoming Chief Executive Officer Silvio Napoli has had time to evaluate the business and its outlook, Morgan Stanley said in a note Wednesday.The company suspended its delivery and capex guidance for the year after a "challenging" Q1, with management reporting $781 million adjusted earnings before interest, taxes, depreciation and amortization loss, according to the note.Morgan Stanley said it expects the losses to remain elevated until the planned 2027 launch of a midsize vehicle. To fund its losses, Lucid has announced a total of $1.05 billion capital raise from Saudi Arabia's Public Investment Fund, Uber (UBER), and a registered public offering, among others, the investment firm said.Morgan Stanley lowered its 2026 EBITDA estimate by 15%, reflecting lower gross margins given recent underperformance as well as higher operating expenses on account of recent workforce reduction charges. The firm also said it continues to expect 26,000 deliveries versus consensus of 25,000 for the year.Morgan Stanley cut its price target on the stock to $5 from $10, while maintaining its underweight rating.Price: $5.90, Change: $-0.35, Percent Change: -5.65%

$LCID$UBER

Wire99d ago

Truist Securities Lifts Assurant Price Target to $290 From $280, Maintains Buy Rating

Assurant (AIZ) has an average rating of overweight and mean price target of $260, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $240.03, Change: $+2.89, Percent Change: +1.22%

$AIZ

Wire99d ago

Boston Beer Likely to See Continued Headwinds From Iran Conflict, Alcohol Sector Decline, Morgan Stanley Says

Boston Beer (SAM) is likely to see continued headwinds amid declining volumes in the alcohol sector and cost pressures from the Iran conflict, Morgan Stanley said in a Wednesday note.US alcohol consumption remain pressured from demographics, cannabis substitution, and health trends, the investment firm said. The company's Twisted Tea and Truly hard seltzer brands also continue to decline, Morgan Stanley noted.The company already narrowed its fiscal 2026 outlook for shipments/depletions to the lower end of its previously issued guidance to reflect energy and aluminum inflation, the brokerage said. Boston Beer now expects shipments/depletions to decline by low-single to mid-single digits.Morgan Stanley lowered its 2026 and 2027 earnings per share forecast for Boston Beer by about 5%.Morgan Stanley also cut its price target on Boston Beer to $220 from $235, with an equal-weight rating.Price: $210.24, Change: $+3.99, Percent Change: +1.93%

$SAM

Wire99d ago

Advanced Micro Devices Faces Expanding AI Exposure, BofA Says

Advanced Micro Devices (AMD) is facing expanding artificial intelligence exposure for its computer chips, BofA Securities said in a note Wednesday.The investment firm said AMD now represents about 6% of the AI total addressable market, and that figure is expected to grow toward over 10% by 2030.BofA highlighted the AMD increased its 2030 forecast for server central processing unit total addressable market to $120 billion from $60 billion previously on "greater emerging agentic AI demand for orchestration CPU."Meanwhile, the company has "additional 'gigawatt-scale' AI customer announcement potential" beyond OpenAI and Meta Platforms (META), the note said.After AMD's Q1 results call, BofA raised the company's 2026 and 2027 pro-forma EPS estimate by 9% each to $7.28 and $11.80, and it is forecasting the company's 2030 EPS potential at over $27, above its management's more than $20 target.BofA reiterated AMD's buy rating and lifted the company's price target to $450 from $310.AMD shares were rising past 15% in Wednesday morning trading.Price: $407.59, Change: $+52.33, Percent Change: +14.73%

$AMD

Wire99d ago

Stifel Nicolaus Adjusts Marriott International Price Target to $352 From $333

Marriott International (MAR) has an average rating of overweight and mean price target of $376.35, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $361.41, Change: $+6.88, Percent Change: +1.94%

$MAR

Wire99d ago

Barclays Adjusts Price Target on Arista Networks to $195 From $184

Arista Networks (ANET) has an average rating of buy and mean price target of $187.07, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $145.44, Change: $-24.78, Percent Change: -14.56%

$ANET

Wire99d ago

Wedbush Adjusts Price Target on Qualys to $125 From $155, Maintains Outperform Rating

Qualys (QLYS) has an average rating of hold and mean price target of $110.35, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $90.06, Change: $-2.08, Percent Change: -2.26%

$QLYS

Wire99d ago

BellRing Brands Sees Weaker Fiscal Q2 on Rising Promotions, Costs, BofA Says

BellRing Brands (BRBR) reported weaker fiscal Q2 results, with slowing ready-to-drink, or RTD, shake growth, rising promotional activity, and increasing cost pressures affecting margins, BofA Securities said in a note Wednesday.Growth in the RTD shake category has slowed to about 8%, compared to prior teens growth rates, while broader sentiment toward small- and mid-cap consumer staples companies has weakened, the firm said, adding there is limited visibility into near-term recovery in revenue or margins.The firm said promotional activity increased sharply in Q2, with about 27% of RTD shake category volume sold on discount, up 8% year-over-year. At the same time, costs are rising, particularly for freight and protein, and these pressures are expected to continue through fiscal 2027, though they may ease moderately.Looking ahead, demand for protein products is still strong overall, the firm said, adding "should BellRing effectively execute against its innovation pipeline, pricing discipline and cost optimization, there is potential for the gap between BellRing and the category to close and move us toward a more constructive stance."BofA downgraded BellRing Brands to underperform from neutral and cut its price target to $10 from $19.Price: $10.89, Change: $+0.26, Percent Change: +2.45%

$BRBR

Wire99d ago

DigitalOcean Seen as Agentic AI Beneficiary Amid Growth Acceleration, BofA Says

DigitalOcean (DOCN) is positioned as a beneficiary of agentic AI, with planned capacity expansion and a higher mix of inferencing workloads expected to drive revenue and free cash flow growth over the long term, BofA Securities said in a Wednesday note.The brokerage said that DigitalOcean reported a "strong" Q1 and raised its 2026 revenue growth guidance. The firm now expects 2027 revenue to grow more than 50% from about 30% previously. DigitalOcean also plans to add 60 megawatts of capacity in 2027 that could bring total committed capacity to about 135 megawatts.The investment firm said that the company has built a "solid" agentic AI platform and is adding significant capacity over the foreseeable future to meet demand. Increased investments are expected to pressure free cash flow margins in the near term, accoridng to the note.BofA increased its 2026 adjusted earnings estimate for the company to $1.29 from $1.11. Analysts polled by FactSet expect $1.22.The firm reiterated its buy rating on the stock and increased its price objective to $200 from $107.Price: $152.65, Change: $-0.13, Percent Change: -0.08%

$DOCN

Wire99d ago

Franklin Resources Shows Early 'Turnaround' Signs as Western Outflows Ease, Morgan Stanley Says

Franklin Resources (BEN) is showing signs of an "early-stage turnaround" as improving core fund flows and moderating outflows at Western Asset Management strengthen business momentum, Morgan Stanley said in a report emailed Wednesday.The investment bank said Franklin has posted nine consecutive quarters of "positive net flows" excluding Western, while quarterly Western-related outflows have declined to about $4 billion from a peak of roughly $68 billion a year earlier.Franklin's "repositioning toward higher-growth areas," including separately managed accounts, ETFs and alternatives, is helping stabilize the firm's "trajectory," though "fee compression" and shifts toward "lower-fee products" remain structural challenges, according to the report.Morgan Stanley upgraded Franklin Resources to equal-weight from underweight and raised the price target to $31 from $21, citing improving "flow dynamics" and a more balanced risk-reward profile.Price: $31.13, Change: $+0.67, Percent Change: +2.20%

$BEN

Showing 7781-7800 of 11095